Caraco Hits Forest Over 3rd Lexapro Patent
The complaint, filed Monday in the U.S. District Court for the Eastern District of Michigan, seeks a declaratory judgment that Caraco has not infringed U.S. Patent Number 7,420,069, which Forest licenses exclusively from H. Lundbeck A/S.
Caraco initially filed its abbreviated new drug application for escitalopram oxalate in May 2006. Forest...
To view the full article, register now.